Ranjit Goudar, MD explains how community oncology practices are expanding hereditary cancer care through genetic testing, workflow redesign, and personalized prevention strategies.
Ranjit Goudar, MD
Advertisement
Articles by Ranjit Goudar, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Sacituzumab Govitecan for First-Line TNBC Treatment
2
FDA Approves Palbociclib Plus Anti-HER2 and Endocrine Therapy as Maintenance in Breast Cancer
3
Emerging Evidence for Earlier Intervention in Low-Risk Polycythemia Vera
4
Why Many Oncologists Still Reach for G-CSF Over Trilaciclib in ES-SCLC
5